Application 065391

Type
ANDA
Sponsor
WOCKHARDT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 250MG BASE/VIALNoNo
002CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 500MG BASE/VIALNoNo
003CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 2GM BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42254-152CEFTRIAXONECEFTRIAXONERebel Distributors CorpANDACurrent
42254-191CEFTRIAXONECEFTRIAXONERebel Distributors CorpANDACurrent
55648-701CEFTRIAXONECEFTRIAXONEWockhardt LimitedANDACurrent
55648-702CEFTRIAXONECEFTRIAXONEWockhardt LimitedANDACurrent
55648-703CEFTRIAXONECEFTRIAXONEWockhardt LimitedANDACurrent
64679-701CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-701CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-701CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-702CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-702CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-702CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-703CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-703CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent
64679-703CEFTRIAXONECEFTRIAXONEWockhardt USA LLC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
44236ORIG2008-09-19